NRPR Nutri Pharmaceuticals Research Inc (PK)

Nutri Pharmaceuticals Research Inc. (Pink Sheets: NRPR) today reported that revenues generated by operations for the second quarter of 2006 were a record $964,545, bringing revenues for the first half of the year for the company to $1,385,545. Gross profit for the second quarter was $416,606 compared to gross profit of $339,000 for the first quarter of the year, which until now had been the company's best quarter. Commenting on the results, Chief Executive Officer and President Godfrey Yew said: "We are thrilled to see revenues and profits continue to increase and are even more excited by what the future holds for the company. We believe the market for our products is enormous. And we will continue to grow. We are developing additional product, which we believe will generate significant excitement in the marketplace." Yew added, "Our facilities are close to capacity with current production, and it is likely the company will expand into larger facilities in the near future." About NPRI Nutri Pharmaceuticals Research Inc. (www.o2pus.com) provides a wide range of powdered oils for functional food, food supplement, dietary supplement, cosmetics, pet food and animal feed applications. The company is one of a select few to be awarded the prestigious Nutrition Business Journal "Product Merit Award" for its patent-pending O2P(TM) Powderization Process. At the heart of its oil powders is the O2P Oil-to-Powder technology. This patent-pending process converts most edible oils, gels or pastes into a free-flowing powder without affecting the isomeric structure, fatty acid profile, color, taste or aroma of the base oil. O2P does not rely on traditional techniques that utilize extremes in heat or cold, or micro-encapsulation technology. The company currently offers more than 50 shelfstable powders. The company can also apply O2P technology to a third party's oil, paste or gel through an arrangement called tolling. Based in Las Vegas, the company has representative sales offices near Chicago, Amsterdam, Guatemala City and Bangkok. Nutri Pharmaceuticals Research Inc. shares are currently traded in the United States on the "NQB (NationalQuotation Bureau) Pinksheets" under the symbol NRPR.PK. Forward-Looking Statements The words "believe," "expect," "anticipate" and other similar expressions generally identify forward-looking statements. Forward-looking statements are based on the company's current expectations and are subject to market, competitive and regulatory factors and the other risks and uncertainties indicated from time to time in the company's filings with the Securities and Exchange Commission. Actual results can differ materially. The company makes no commitment to disclose any revisions to forward-looking statements.